This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

3 Mar 2011

Genzyme Completes Intermediate Sale

American biotechnology company Genzyme has completed the sale of its pharmaceutical intermediates business.

Genzyme, an American biotechnology company based in Massachusetts, has completed the sale of its pharmaceutical intermediates business as part of a plan to focus on core growth sectors.


Details of the sale to International Chemical Investors Group were not disclosed, but it was revealed that the buyer would start production on materials for a late-stage drug in development for Gaucher disease.


Genzyme itself is in the process of being acquired by French drug maker Sanofi-Aventis, who agreed to pay $20.1bn ($74 per share) after months of intense haggling over the company's value.


Related News